In industrialized countries, heart failure has developed into a leading cause of death and
hospitalization. It represents one of the most relevant drivers of health-related costs and is …

Heart failure is approaching epidemic proportions and has become a major public health
problem. It is the only cardiovascular disorder with increasing incidence and prevalence …

Heart failure (HF) affects many patients worldwide every year. It represents a leading cause
of hospitalization and still, today, mortality remains high, albeit the progress in treatment …

Sleep apnea is frequently observed in patients with heart failure (HF). In general, sleep
apnea consists of two types: obstructive and central sleep apnea (OSA and CSA …

Opinion statement Heart failure is a highly prevalent disorder, with significant economic
impact, and is associated with excess morbidity and mortality. One factor that may contribute …

Purpose of review In this review, we discuss the current treatment options for sleep-
disordered breathing (SDB) in patients with heart failure (HF). We address the role of …

It is likely sleep apnea is highly prevalent in patients with congestive heart failure (CHF).
However, as awareness is low and consensus guidelines do not exist, sleep apnea is not …

Sleep-disordered breathing (SDB) has become an increasingly recognized cause of
morbidity and mortality in adults, and is largely underdiagnosed and undertreated. SDB is …

Obstructive sleep apnea (OSA) is highly prevalent among patients with asymptomatic left
ventricular systolic and diastolic dysfunction and congestive heart failure, and if untreated …

Patients with heart failure with reduced ejection fraction and predominant central sleep
apnea pose treatment challenges. A system review and meta-analysis of randomized …